Argá Medtech completes enrollment of paroxysmal AF cohort in COHERENT-AF
The company announced that 150 intention-to-treat subjects were enrolled in the paroxysmal atrial fibrillation cohort across 27 sites in Europe and the United States. Enrollment of the persistent AF cohort is ongoing and expected to finish in the next two months.
Primary source
Company press release (PR Newswire), November 11, 2026
Argá Medtech Completes Enrollment of Paroxysmal AF Cohort in the COHERENT-AF Pivotal IDE Study
Read the source: Argá Medtech Completes Enrollment of Paroxysmal AF Cohort in the COHERENT-AF Pivotal IDE Study prnewswire.com
Machine-summarized from the source above; not independently reported. How we use automation